Type 2 diabetes linked to 53% higher Alzheimer’s risk, major review finds

Type 2 diabetes linked to 53% higher Alzheimer’s risk, major review finds


A major research review led by Curtin University has found that people with type 2 diabetes face a significantly higher risk of developing Alzheimer’s disease. The findings provide a clearer picture of the connection between diabetes and Alzheimer’s, including how much the risk increases and how frequently new cases occur.

Researchers analyzed data from 40 studies in a systematic review and meta-analysis. They estimated that for every 1,000 people with type 2 diabetes, approximately 4.7 would develop Alzheimer’s disease over the course of one year.

A separate analysis found that people with type 2 diabetes had a 53 percent higher adjusted relative risk of developing Alzheimer’s compared with those without the condition.

Understanding the Link Between Diabetes and Alzheimer’s

Study author Dr. Emmanuel Adewuyi, an NHMRC Investigator Fellow at the Curtin School of Population Health, explained that the findings offer a more precise understanding of Alzheimer’s risk among people with type 2 diabetes.

Unlike previous research reviews that often examined multiple forms of diabetes or dementia together, this analysis concentrated specifically on type 2 diabetes and Alzheimer’s disease. It also measured how frequently people with diabetes developed Alzheimer’s, providing an additional perspective on the connection between the two conditions.

“While many earlier reviews combined different types of diabetes or dementia, this review focused specifically on type 2 diabetes and Alzheimer’s disease and estimated how often new cases occurred,” Dr. Adewuyi said.

“Relative risk tells us how two groups compare, while incidence tells us how often new cases occur: putting those numbers together gives us a clearer picture of the burden of Alzheimer’s disease among people living with type 2 diabetes.”

The study, “Incidence and risk of Alzheimer’s disease in individuals with type 2 diabetes: a systematic review and meta-analysis,” was published in Alzheimer’s Research & Therapy.



Source link